Four Injectafer Lawsuits To Go Before Juries For Trial Dates Set to Begin in 2023
Average Injectafer lawsuit payouts awarded in early bellwether trials could have a major impact on settlement negotiations to resolve hundreds of claims
Average Injectafer lawsuit payouts awarded in early bellwether trials could have a major impact on settlement negotiations to resolve hundreds of claims
Injectafer manufacturers failed to disclose the potential adverse health risks for years, according to the iron deficiency infusion lawsuit.
Plaintiff says the label for Injectafer failed to warn the medical community of the risk that the iron injections could cause severely low phosphorous blood levels
Drug manufacturers failed to warn about the risks of Injectafer iron deficiency treatment, the severe HPP lawsuit claims
Plaintiff claims manufacturers hid Injectafer iron infusion side effects from the medical community and patients
Drug manufacturers never warned the medical community or patients about the risks of Injectafer long-term side effects, the lawsuit alleges.
Hypophosphatemia lawsuit alleges that woman would have avoided dangerous drops in blood phosphate levels if adequate Injectafer warnings had been provided
Structural racism, lack of healthcare access and other factors have led to half of children with sickle cell anemia not getting proper treatment, according to the researchers.
Side effects of Injectafer iron infusions have been linked to a potentially life-threatening condition known as severe hypophosphatemia, according to dozens of lawsuits pending in Pennsylvania federal court
Plaintiff claims the manufacturers failed to warn about the risk of critically low phosphate levels caused by Injectafer iron infusions.